Friday, April 23, 2027

  • Early Cancer Detection & Precision Cancer Management 2027
    04/23/2027 - 7:00am to 04/24/2027 - 2:00pm
    April 23-24, 2027 - The Westin Carlsbad Resort & Spa - Carlsbad, CA     This course offers Live (in-person) and Livestream (virtual) attendance options Join leading academic, clinical, and industry experts to explore innovations that are transforming early cancer detection. This activity highlights advances in multi-cancer detection (MCD) as a population screening tool, cell-free DNA (cfDNA), multimodal detection platforms and precision cancer treatment while addressing clinical implementation, collaboration, and strategies to accelerate translation into practice.
  • Updates in Pediatric Allergy & Dermatology
    04/23/2027 - 7:00am to 04/24/2027 - 1:00pm
    April 23-24, 2027 - Mayo Clinic – Jacksonville, Florida This course offers Live (in-person) and Livestream (virtual) attendance options This CME course will be designed for primary care, Allergy, and Dermatology physicians, APPs and other healthcare team members to provide the most up-to-date evidence-based recommendations and address education gaps. Mayo Clinic experts will highlight advances and updates in the field of pediatric Allergy and Dermatology by covering a wide range of topics including food allergy, atopic dermatitis, asthma, allergic rhinitis, acne, alopecia, and more. This course will differ from other currently available courses by focusing on topics commonly seen and treated in the primary care office while addressing subspeciality care available in Allergy and Dermatology clinics.
  • Orthopedic Infectious Diseases 2027
    04/23/2027 - 1:15pm to 04/24/2027 - 3:30pm
    April 23-24, 2027 - Mayo Clinic - Rochester, Minnesota This course offers Live (in-person) and Livestream (virtual) attendance options This Mayo Clinic course, specifically designed for infectious diseases practitioners, focuses exclusively on the complexities of managing orthopedic infections. It features dynamic, case-based modules led by experts in the field, addressing both diagnostic and therapeutic challenges. Key topics include controversies and updates in the use of DAIR (debridement, antibiotics, and implant retention) for prosthetic joint infections, the role of dalbavancin in treatment regimens, and strategies for managing fracture-related infections. Each session is followed by engaging, case-based group discussions, facilitated by a panel of seasoned professionals.